Institutional members access full text with Ovid®

Share this article on:

Is ICGA Still Relevant in Inflammatory Eye Disorders? Why This Question Has to Be Dealt With Separately From Other Eye Conditions

Herbort, Carl P. MD, PD, FEBOphth*; Neri, Piergiorgio MD, PhD; El Asrar, Ahmed A. MD, PhD; Gupta, Vishali MD§; Kestelyn, Philippe MD; Khairallah, Moncef MD**; Mantovani, Alessandro MD††; Tugal-Tutkun, Ilknur MD‡‡; Papadia, Marina MD, PhD§§

doi: 10.1097/IAE.0b013e3182618d43

*Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialised Care (COS), Lausanne and University of Lausanne, Lausanne, Switzerland

The Eye Clinic, Polytechnic University of Marche, Ancona, Italy

Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

§Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India

Department of Ophthalmology, University of Ghent, Ghent, Belgium

**Department of Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia

††Unit of Ophthalmology, Valduce Hospital, Como, Italy

‡‡Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

§§Department of Neurosciences, Eye Clinic, Ophthalmology and Genetics, University of Genova, Genova, Italy

The authors have no conflicts of interest to disclose.

© The Ophthalmic Communications Society, Inc.